SELECT LANGUAGE BELOW

Pfizer triumphs in $10 billion competition for Metsera against Novo Nordisk

Pfizer triumphs in $10 billion competition for Metsera against Novo Nordisk

Pfizer, the US pharmaceutical giant, has clinched a $10 billion agreement with Metsala, a developer of obesity medications. This marks the end of a competitive bidding struggle with Danish rival Novo Nordisk. Metsala opted for Pfizer’s more cautious offer on Friday, mentioning the risks associated with Novo’s proposal, which it had initially deemed more favorable. […]

Stocks with the largest premarket changes: Oracle, GameStop, Novo Nordisk, Synopsys and others

Stocks with the largest premarket changes: Oracle, GameStop, Novo Nordisk, Synopsys and others

Market Movements: Key Company Updates Oracle experienced a remarkable surge of 32% after revealing that revenues from its Multicloud databases from Amazon, Google, and Microsoft skyrocketed by a staggering 1,529% in the last quarter. This growth allowed investors to overlook weaker-than-expected earnings from some companies in the first quarter. Meanwhile, GameStop, often categorized as a […]

Novo Nordisk to lay off 9,000 employees as part of restructuring efforts

Novo Nordisk to lay off 9,000 employees as part of restructuring efforts

Novo Nordisk, the company behind Wegovy, has announced a significant restructuring that will eliminate 9,000 jobs, which represents about 11.5% of its workforce, with the goal of saving $1.26 billion annually. According to a statement, “Novo Nordisk today revealed a company-wide transformation aimed at simplifying structures, accelerating decision-making, and reallocating resources to boost growth in […]

Hims Stock Increases as FDA Releases “Green List,” Novo Nordisk Shares Decrease

Hims Stock Increases as FDA Releases “Green List,” Novo Nordisk Shares Decrease

Shares of HIMS & HERS (HIMS) increased by 2.6% on Monday following the FDA’s release of a “green list” of global suppliers offering ingredients that meet GLP-1 standards. This announcement indicates that the company will begin to take on compound interest, allowing them to gather active ingredients and create customized versions of GLP-1 weight loss […]

Novo Nordisk and GoodRx offer Ozempic at half price for cash-paying customers.

Novo Nordisk and GoodRx offer Ozempic at half price for cash-paying customers.

Novo Nordisk and GoodRx recently announced a partnership aimed at making Ozempic and Wegovy products more affordable for cash-paying patients. Starting this week, customers can buy Novo Nordisk’s Semaglutide Pen products for $499 a month through GoodRx. Typically, these medications, such as Ozempic, cost over $1,000 without insurance. “The demand for GLP-1 medications is at […]

Trump’s GLP-1 Initiative Might Help Novo Nordisk and Eli Lilly

Trump's GLP-1 Initiative Might Help Novo Nordisk and Eli Lilly

Concerns in the Pharmaceutical Sector Amid Tariff Threats This week, a significant concern arose for drugmakers as President Trump proposed implementing tariffs of up to 250% on imported medications. This news has unsettled the healthcare industry, leading to a 2.74% decline over the past five days, contributing to an overall drop of 5.13% this year. […]

Novo Nordisk stock falls further, decreasing by 3% following profit alert

Novo Nordisk stock falls further, decreasing by 3% following profit alert

Stock on the move: Adidas down 8% as JDE Peet’s jump Shoppers were spotted at the Adidas store in Miami, Florida, on April 4, 2025. Many companies’ earnings are influencing market fluctuations today. The FTSE 100 saw a 0.3% drop by noon in London, while the CAC40 in France had a 0.43% rise. In Germany, […]